Biblio

Export 2801 results:
Author Keyword Title Type [ Year(Asc)]
2022
A. Xu, Kouznetsova, V. L., and Tsigelny, I. F., “Alzheimer's Disease Diagnostics Using miRNA Biomarkers and Machine Learning.”, J Alzheimers Dis, vol. 86, no. 2, pp. 841-859, 2022.
A. Ivan B. Posis, Tarraf, W., Gonzalez, K. A., Soria-Lopez, J. A., Léger, G. C., Stickel, A. M., Daviglus, M. L., Lamar, M., Zeng, D., and González, H. M., “Anticholinergic Drug Burden and Neurocognitive Performance in the Study of Latinos-Investigation of Neurocognitive Aging.”, J Alzheimers Dis, vol. 86, no. 1, pp. 53-65, 2022.
O. Lerch, Pařízková, M., Vyhnálek, M., Nedelska, Z., Hort, J., and Laczó, J., “APOEɛ4 Allele Moderates the Association Between Basal Forebrain Nuclei Volumes and Allocentric Navigation in Older Adults Without Dementia.”, J Alzheimers Dis, vol. 86, no. 1, pp. 155-171, 2022.
S. J. McCarter, Lesnick, T. G., Lowe, V. J., Rabinstein, A. A., Przybelski, S. A., Algeciras-Schimnich, A., Ramanan, V. K., Jack, C. R., Petersen, R. C., Knopman, D. S., Boeve, B. F., Kantarci, K., Vemuri, P., Mielke, M. M., and Graff-Radford, J., “Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds.”, J Alzheimers Dis, 2022.
H. I. L. Jacobs, O'Donnell, A., Satizabal, C. L., Lois, C., Kojis, D., Hanseeuw, B. J., Thibault, E., Sanchez, J. S., Buckley, R. F., Yang, Q., DeCarli, C., Killiany, R., Sargurupremraj, M., Sperling, R. A., Johnson, K. A., Beiser, A. S., and Seshadri, S., “Associations Between Brainstem Volume and Alzheimer's Disease Pathology in Middle-Aged Individuals of the Framingham Heart Study.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1603-1609, 2022.
V. I. Dobromyslin and Megherbi, D. B., “Augmenting Imaging Biomarker Performance with Blood-Based Gene Expression Levels for Predicting Alzheimer's Disease Progression.”, J Alzheimers Dis, 2022.
S. R. Alves, Silva, Cda Cruz E., Martins, I., Henriques, A. Gabriela, and Silva, O. A. B. da Cru, “A Bioinformatics Approach Toward Unravelling the Synaptic Molecular Crosstalk Between Alzheimer's Disease and Diabetes.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1917-1933, 2022.
H. Wang, Wang, G., Billings, R., Li, D., Haase, S. R., Wheeler, P. F., Vance, D. E., and Li, W., “Can Diet Supplements of Macular Pigment of Lutein, Zeaxanthin, and Meso-zeaxanthin Affect Cognition?”, J Alzheimers Dis, 2022.
A. A. Hosseini, Brown, T., Mannino, L., Gran, B., Junaid, K., and Mukaetova-Ladinska, E. B., “Clinical Utility of Cerebrospinal Fluid Aβ42 and Tau Measures in Diagnosing Mild Cognitive Impairment in Early Onset Dementia.”, J Alzheimers Dis, 2022.
A. A. Diaz Baquero, Franco-Martín, M. A., Vidales, E. Parra, Toribio-Guzmán, J. Miguel, Bueno-Aguado, Y., Abad, F. Martínez, Bartolomé, M. V. Perea, Asl, A. Mahmoudi, and van der Roest, H. G., “The Effectiveness of GRADIOR: A Neuropsychological Rehabilitation Program for People with Mild Cognitive Impairment and Mild Dementia. Results of a Randomized Controlled Trial After 4 and 12 Months of Treatment.”, J Alzheimers Dis, vol. 86, no. 2, pp. 711-727, 2022.
J. I. Broussard, Redell, J. B., Maynard, M. E., Zhao, J., Moore, A., Mills, R. W., Hood, K. N., Underwood, E., Roysam, B., and Dash, P. K., “Impaired Experience-Dependent Refinement of Place Cells in a Rat Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1907-1916, 2022.
A. Barlach Pritchard, Fabian, Z., Lawrence, C. L., Morton, G., Crean, S. J., and Alder, J. E., “An Investigation into the Effects of Outer Membrane Vesicles and Lipopolysaccharide of Porphyromonas gingivalis on Blood-Brain Barrier Integrity, Permeability, and Disruption of Scaffolding Proteins in a Human in vitro Model.”, J Alzheimers Dis, vol. 86, no. 1, pp. 343-364, 2022.
M. Assogna, Motta, C., Bonní, S., Borghi, I., Casula, E. P., Martorana, A., and Koch, G., “Isolated Amyloid-β Pathology Is Associated with Preserved Cortical Plasticity in APOE4 Alzheimer's Disease Patients.”, J Alzheimers Dis, vol. 86, no. 2, pp. 773-778, 2022.
Ede Paula F. Resende, Ketelle, R., Karydas, A., Allen, I., Grinberg, L. T., Spina, S., Seeley, W. W., Perry, D. C., Miller, B., and Naasan, G., “Late-Onset Alcohol Abuse as a Presenting Symptom of Neurodegenerative Diseases.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1073-1080, 2022.
T. Kawarabayashi, Nakamura, T., Sato, K., Seino, Y., Ichii, S., Nakahata, N., Takatama, M., Westaway, D., St George-Hyslop, P., and Shoji, M., “Lipid Rafts Act as a Common Platform for Amyloid-β Oligomer-Induced Alzheimer's Disease Pathology.”, J Alzheimers Dis, 2022.
M. C. Fitzhugh and Pa, J., “Longitudinal Changes in Resting-State Functional Connectivity and Gray Matter Volume Are Associated with Conversion to Hearing Impairment in Older Adults.”, J Alzheimers Dis, vol. 86, no. 2, pp. 905-918, 2022.
K. Ceyzériat, Tournier, B. B., Millet, P., Dipasquale, G., Koutsouvelis, N., Frisoni, G. B., Garibotto, V., and Zilli, T., “Low-Dose Radiation Therapy Reduces Amyloid Load in Young 3xTg-AD Mice.”, J Alzheimers Dis, vol. 86, no. 2, pp. 641-653, 2022.
S. E. O'Bryant, Petersen, M., Hall, J., and Johnson, L., “Metabolic Factors Are Related to Brain Amyloid Among Mexican Americans: A HABS-HD Study.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1745-1750, 2022.
C. LoBue, Kelley, B. J., Hart, J., Helphrey, J., Schaffert, J., C Cullum, M., Peters, M. E., and Douglas, P. M., “Mild Traumatic Brain Injury is Related to Elevated Cerebrospinal Fluid Tau in Alzheimer's Disease Dementia.”, J Alzheimers Dis, 2022.
A. A. Sandberg, Manning, E., Wilkins, H. M., Mazzarino, R., Minckley, T., Swerdlow, R. H., Patterson, D., Qin, Y., and Linseman, D. A., “Mitochondrial Targeting of Amyloid-β Protein Precursor Intracellular Domain Induces Hippocampal Cell Death via a Mechanism Distinct from Amyloid-β.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1727-1744, 2022.
G. Weinstein, O'Donnell, A., Davis-Plourde, K., Zelber-Sagi, S., Ghosh, S., DeCarli, C. S., Thibault, E. G., Sperling, R. A., Johnson, K. A., Beiser, A. S., and Seshadri, S., “Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1371-1383, 2022.
S. Cardoso, Silva, D., Alves, L., Guerreiro, M., and de Mendonça, A., “The Outcome of Patients with Amyloid-Negative Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 86, no. 2, pp. 629-640, 2022.
B. Rippon, Palta, P., Tahmi, M., Sherwood, G., Soto, L., Cespedes, S., Mesen, Y., He, H., Laing, K., Moreno, H., Teresi, J., Razlighi, Q., Brickman, A. M., Zetterberg, H., and Luchsinger, J. A., “Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics.”, J Alzheimers Dis, 2022.
Y. Dou, Liu, S., Li, Y., Wu, H., Chen, H., and Ji, Y., “Plasma Cholesterol Levels as Potential Nutritional Biomarkers for Lewy Body Dementia.”, J Alzheimers Dis, vol. 86, no. 2, pp. 779-786, 2022.
D. J. Jester, Vyhnálek, M., Andel, R., Marková, H., Nikolai, T., Laczó, J., Matuskova, V., Cechova, K., Sheardova, K., and Hort, J., “Progression from Subjective Cognitive Decline to Mild Cognitive Impairment or Dementia: The Role of Baseline Cognitive Performance.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1763-1774, 2022.

Pages